1st Quarter Financial Results for FYE 3/2008 (Consolidated)
Name of listed company: TERUMO CORPORATION( URL http://www.terumo.com/ )Company code number: 4543
Representative:
Akira Takahashi, President
Please address all communications to:
Kunio Kimishima, General Manager, Corporate Communication Dept.

July 25, 2007

Exchange where listed: TSE
Location of headquarters (prefecture):
Tokyo

Phone: +81 / 3-3217 - 6550

1. Consolidated Financial Highlights for the three months ended June 2007 - Unaudited(From April 1, 2007 to June 30, 2007)(1) Consolidated financial results(Note: The amounts shown below ignore values of less than a million yen)
Net sales

Operating income(Millions of yen)Three months ended June, 2007
Three months ended June, 2006
Year ended March, 2007

% (Millions of yen)

75,46964,319276,439

17.3
9.5

Net income per share

16,986
13,46058,455

Ordinary income% (Millions of yen)

26.2
11.8

Net income% (Millions of yen)

18,595
13,45358,025

38.2
9.1

%

13,142
8,045
37,23263.4
4.8

Net income per share,
fully diluted(Yen)(Yen)

Three months ended June, 2007
66.11
Three months ended June, 2006
39.63
Year ended March, 2007
185.00* The percentages shown next to net sales, operating income, ordinary income and net income represent year-on-year changes.
(2) Consolidated financial position
Total assets
June 30, 2007
June 30, 2006
March 31, 2007

(Millions of yen)

(Millions of yen)

383,819
346,905
367,147

305,823
275,147
289,248(3) Consolidated statements of cash flows
Cash flows fromoperating activities
Three months ended June, 2007
Three months ended June, 2006
Year ended March, 2007

Shareholders’ equity

Cash flows frominvesting activities

Equity ratio

Book value per share%

(Yen)

79.7
79.3
78.8
Cash flows fromfinancing activities

1,537.97
1,355.24
1,454.71
Cash and cash equivalents,
end of the period(Millions of yen)

(Millions of yen)

(Millions of yen)

(Millions of yen)

11,9905,761
43,123(8,107)(3,500)(19,917)(3,188)(3,612)(28,637)

44,38046,62043,049(4) Changes in scope of consolidation and in application of the equity method in significant subsidiaries.
(elimination): None
Consolidation (new) :None
Equity method (new) :None(elimination): None
(5) All financial results for the consolidated financial period from April 1, 2007 to June 30, 2007 are not audited
by independent auditors.

2. Consolidated Financial Statements(1) Consolidated Balance Sheet

I.Current Assets
Cash and cash equivalents
Trade receivable notes/accounts
Inventories
Other current assets
II.Fixed Assets
1. Tangible fixed assets
Building and structures
Machinery and transportation equipment
LandConstruction in progress
Other tangible assets
2. Intangible fixed assets
3. Investments and other assets
Investment in securities
Other investments and other assets
Total Assets

June 30, 2006
Amount%160,535
46.3
46,62060,37042,545
10,998186,370
53.7
110,23631.8
42,867
29,174
20,257
10,675
7,261
41,12011.8
35,013
10.1
28,8786,135
346,905
100.0

June 30, 2007
Amount%179,903
46.9
47,86971,59247,552
12,888203,91653.1
115,47430.1
45,28333,73820,3739,397
6,681
41,09910.7
47,341
12.3
42,704
4,637
383,819
100.0(Millions of yen)March 31, 2007
Amount%171,576
46.7
44,536
69,15545,631
12,253
195,570
53.3
115,64331.5
45,09232,004
20,296
11,493
6,756
40,524
11.1
39,402
10.7
34,802
4,599
367,147
100.0

I.Current Liabilities
Trade payable notes/accounts
Short-term bank loans
Other current liabilities
II.Long-term Liabilities
Long-term bank loans
Reserve for retirement allowance
Other long-term liabilities
Total Liabilities
I.Shareholders' Equity
Capital stock
Capital surplus
Retained earnings
Treasury stock
II.Evaluation difference and foreign currency exchange adjustments
Evaluation difference of investment securities
Foreign currency translation adjustments
Ⅲ.Minority Interests
Total Net Assets

56,721
22,5383,181
31,002
15,035
11,844
3,191
71,757
272,754
38,71659,030188,462(13,455)
2,347
5,436
(3,089)46
275,147

0.0
79.3

63,27125,875
246
37,14914,724
456
6,137
8,131
77,996
289,461
38,71659,030225,175(33,461)
16,267
12,3203,946
93305,823

0.0
79.7

65,891
25,725236
39,92912,007
436
6,506
5,064
77,899279,50738,71659,030215,213(33,453)
9,672
8,947
725
68
289,248

0.0
78.8

Total Liabilities and Net Assets

346,905

100.0

383,819100.0

367,147

100.0

16.4

4.3

20.7
78.6

0.7

16.5

3.8

20.3
75.4

4.3

17.9

3.3

21.2
76.1

2.7

(2) Consolidated Statement of Income

Net sales
Cost of sales
Gross profit
Selling, general and administrative expenses
Operating income
Non-operating income / expenses
Ordinary income
Extraordinary income / expenses
Income before taxes
Corporate, inhabitant and enterprise taxes
Minority interests
Net income for the period

Three months ended Three months ended
June 30, 2006
June 30, 2007
Amount%Amount%64,319100.075,469
100.0
28,44744.3
33,96445.0
35,87255.7
41,50455.0
22,41234.8
24,51832.5
13,46020.9
16,986
22.5
(6)
1,609
13,45320.9
18,595
24.6
(678)
1,040
12,775
19.9
19,636
26.0
4,729
6,480
0
12
8,045
12.5
13,142
17.4(Millions of yen)
Year ended
March 31, 2007
Amount%276,439100.0
123,11244.5
153,32655.5
94,871
34.3
58,45521.2(429)
58,02521.0(952)
57,072
20.6
19,82416
37,232
13.5

(3) Statement of changes in net assets

Three-month period ended June 30, 2007 (from April 1, 2007 to June 30, 2007)

Beginning of period
Changes during this fiscal accounting period
Cash dividends from retained earnings
Net income for the period
Acquisition of treasury stock(Decrease) increase of items during the period except those included inshareholders' equity
Total changes during this fiscal accounting periodEnding of period

Beginning of period
Changes during this fiscal accounting period
Cash dividends from retained earnings
Net income for the period
Acquisition of treasury stock(Decrease) increase of items during the period except those included inshareholders' equity
Total changes during this fiscal accounting periodEnding of period(Millions of yen)

Shareholders' equity
Retained
Capital stock
Capital surplus
Treasury stockearnings
38,71659,030215,213(33,453)(3,180)13,142

38,71659,0309,962
225,175

Shareholders'equity total
279,507(7)(3,180)13,142(7)(7)(33,461)

9,954
289,461

Evaluation difference and foreign currency exchange
adjustments
Evaluation
Evaluation
Foreign currency difference and Minority interests Net assets total
difference of
foreign currencytranslation
investmentexchange
adjustments
securities
adjustments total
8,947
725
9,672
68
289,248(3,180)13,142
(7)
3,373
3,373
12,320

3,221
3,221
3,946

6,594
6,594
16,267

25
25
93

6,620
16,574
305,823

Shareholders' equity
Retained
Capital stock
Capital surplus
Treasury stockearnings
38,71659,030183,391(13,449)

Shareholders'equity total
267,689

Fiscal year ended March 31, 2007 (from April 1, 2006 to March 31, 2007

Beginning of period
Changes during this fiscal accounting period
Cash dividends from retained earnings
Directors' bonuses
Net income for the period
Acquisition of treasury stock(Decrease) increase of items during the period except those included inshareholders' equity
Total changes during this fiscal accounting periodEnding of period

Beginning of period
Changes during this fiscal accounting period
Cash dividends from retained earnings
Directors' bonuses
Net income for the period
Acquisition of treasury stock(Decrease) increase of items during the period except those included inshareholders' equity
Total changes during this fiscal accounting periodEnding of period(5,278)(132)
37,232

38,71659,03031,821
215,213(20,004)(5,278)(132)
37,232(20,004)(20,004)(33,453)

11,817
279,507

Evaluation difference and foreign currency exchange
adjustments
Evaluation
Evaluation
Foreign currency difference and Minority interests Net assets total
difference of
foreign currencytranslation
investment
exchange
adjustments
securities
adjustments total
7,367(1,747)5,619
49273,359(5,278)(132)
37,232(20,004)
1,580
1,580
8,947

2,472
2,472
725

4,052
4,052
9,672

18
18
68

4,071
15,888289,248

(4) Consolidated Statement of Cash Flows

Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Effect of exchange rate changes on cash and cash equivalents
Change in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of period

Three months ended
June 30, 2006
5,761
(3,500)(3,612)8(1,343)
47,963
46,620Three months ended
June 30, 2007
11,990(8,107)(3,188)637
1,331
43,04944,380(Millions of yen)
Year ended
March 31, 2007
43,123(19,917)(28,637)516(4,914)47,96343,049June 30, 2006
187,922

June 30, 2007
200,988(Millions of yen)March 31, 2007
196,452

Three months ended
June 30, 2006
3,826

Three months ended
June 30, 2007
3,844

(Millions of yen)
Year ended
March 31, 2007
16,792Three months ended
June 30, 2006
22
43-

Three months ended
June 30, 2007
1,059

(Millions of yen)
Year ended
March 31, 2007
43
-

4
12728

18-

(5)Notes
Relating to balance sheet

Accumulated depreciation of tangible assets

Relating to statement of income
Main items among selling, general and administrative expensesR&D expenditure
Main items among extraordinary income / expenses

Gain on sales of property, plant and equipment
Gain on reversal of allowance for bad debts
Gain arising from change in equity accounted interest
Loss on disposal of property, plant and equipment
Loss on restructuring in overseas operation
Compensation for retired directors
Provision for retirement benefits for directors and corporate auditors

19560
12728

3. Segment Information(1) Sales results by product segment(Millions of yen)Three months ended Three months ended
June 30, 2006
June 30, 2007
Amount%Amount%Disposable medical equipment
Pharmaceuticals
Blood transfusion systems
General hospital products
Catheter systems
Cardiovascular systems
Vascular grafts
Cardiac & Vascular products
CAPD systems
Diabetes care products
Other productsHome health care products
TotalChanges
Amount%18,09428.1%

20,691

27.4%

2,596

14.3%

8,733

13.6%

10,175

13.5%

1,441

16.5%

4,340

6.8%

5,850

7.8%

1,510

34.8%

31,16848.5%

36,716

48.7%

5,548

17.8%

14,95423.3%

19,108

25.3%

4,154

27.8%

8,933

13.9%

9,601

12.7%

668

7.5%

2,394

3.7%

2,514

3.3%

119

5.0%

26,28240.9%

31,224

41.3%

4,941

18.8%

1,808

2.8%

1,769

2.3%

(39)

(2.2%)

2,852

4.4%

3,454

4.6%

602

21.1%

2,208

3.4%

2,304

3.1%

96

4.4%

7,528 10.0%
75,469 100.0%659
11,1499.6%
17.3%

6,868 10.6%
64,319 100.0%

Note 1) Main Products belonging to each product segment
Product segment

Main Products

Disposable medical equipment

Syringes, Needles, Solution Administration sets, I.V.catheters,
Blood collection tubes, Electronic medical devices, etc.
I.V.solution, Prefilled syringes, Nutritional products, etc.
Blood bags, Blood transfusion administration sets, medical
electronic devices for blood collection, etc.
PTCA dilation catheters, Coronary stents, Guide wires,
Angiographic catheters, Cerebral aneurysm coils, etc.
Roller pumps, Hollow fiber oxygenators, Blood circuits, etc.
Artificial vascular grafts
Dialysis solution, etc.
Blood glucose monitors, etc.
Home oxygen systems, Home nutritional products, Digital
Thermometers, Electronic sphygmomanometers, etc.

Pharmaceuticals
Blood transfusion systems
Catheter systems
Cardiovascular systems
Vascular grafts
CAPD systems
Diabetes care products
Other products(2) Sales results by region(Millions of yen)Three months ended Three months ended
June 30, 2006
June 30, 2007
Amount%Amount%JapanEurope
America
Asia and Others
Total

ChangesAmount%35,405

55.1%

39,108

51.8%

3,702

10.5%

11,47817.8%

14,271

18.9%

2,792

24.3%

11,77718.3%

14,508

19.2%

2,730

23.2%

7,582 10.1%
75,469 100.0%

1,924
11,149

34.0%
17.3%

5,657
8.8%
64,319 100.0%